Institutional Fund
Exome Asset Management LLC
New York, NYCIK 20119327 filings on record
Portfolio Value
$169.95M
Q1 2026
Holdings
45
Reported positions
New Buys
14
Opened this quarter
QoQ Change
-16.0%
from $202.43M
Portfolio Value Trend
Reported 13F value by quarter
Portfolio value trend — upgrade to see history
UpgradeTop Allocations
Largest positions by weight
- Praxis Precision Medicines I8.6%
- Cogent Biosciences Inc6.3%
- Enliven Therapeutics Inc5.1%
- Ionis Pharmaceuticals Inc4.9%
- Guardant Health Inc4.5%
- Cytokinetics Inc4.0%
- Other66.6%
Portfolio Holdings
45 positions · Q1 2026
| # | Security | Shares | Value | % Port. | Δ Shares | Activity |
|---|---|---|---|---|---|---|
| 1 | Praxis Precision Medicines I | 45.5K | $14.65M | 8.6% | −12.7K | Reduced |
| 2 | Cogent Biosciences Inc | 278.5K | $10.72M | 6.3% | −27.0K | Reduced |
| 3 | Enliven Therapeutics Inc | 220.1K | $8.63M | 5.1% | −2.2K | Reduced |
| 4 | Ionis Pharmaceuticals Inc | 110.1K | $8.26M | 4.9% | −6.5K | Reduced |
| 5 | Guardant Health Inc | 82.7K | $7.64M | 4.5% | −15.4K | Reduced |
| 6 | Cytokinetics Inc | 103.7K | $6.84M | 4.0% | −21.0K | Reduced |
| 7 | Eli Lilly & Co | 7.0K | $6.45M | 3.8% | −840 | Reduced |
| 8 | Alumis Inc | 279.2K | $6.15M | 3.6% | −13.1K | Reduced |
| 9 | Bridgebio Pharma Inc | 67.5K | $5.01M | 2.9% | −13.2K | Reduced |
| 10 | Vera Therapeutics Inc | 115.0K | $4.63M | 2.7% | −9.4K | Reduced |
35 more holdings on Premium
See this fund's complete portfolio, full position changes, and activity history.
Unlock full portfolio